0.76 - 0.86
0.53 - 11.72
227.7K / 102.3K (Avg.)
-0.11 | -7.01
Analyze DCF forecasts for the company and compare them with competitors.
4.12K
Revenue has decreased from the previous period.
-71.77%
Revenue growth rate is unchanged from the previous period.
-2.47K
EBITDA has increased from the previous period.
-60.00%
EBITDA margin is unchanged from the previous period.
-2.47K
EBIT has increased from the previous period.
-60.00%
EBIT margin is unchanged from the previous period.
3.65K
Depreciation has decreased from the previous period.
4.12K
Total cash has decreased from the previous period.
100.00%
Cash percentage is unchanged from the previous period.
3.40K
Receivables have decreased from the previous period.
82.66%
Receivables percentage is unchanged from the previous period.
2.46K
Inventories have decreased from the previous period.
59.73%
Inventory percentage is unchanged from the previous period.
4.12K
Accounts payable has decreased from the previous period.
100.00%
Payables percentage is unchanged from the previous period.
-3.29K
Capital expenditure has decreased from the previous period.
-80.00%
CapEx percentage is unchanged from the previous period.
6.08%
WACC is unchanged from the previous period.
16.36%
Cost of equity is unchanged from the previous period.
3.71%
Cost of debt is unchanged from the previous period.
2.68
Beta is unchanged from the previous period.
15.93M
Diluted shares outstanding is unchanged from the previous period.
50.65M
Total debt is unchanged from the previous period.
11.73M
Total equity is unchanged from the previous period.
62.39M
Total capital is unchanged from the previous period.
81.19%
Debt weighting is unchanged from the previous period.
18.81%
Equity weighting is unchanged from the previous period.
-2.46K
EBIAT has increased from the previous period.
2.33K
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
4.64K
Terminal value is unchanged from the previous period.
-957.93K
Enterprise value is unchanged from the previous period.
-21.61M
Net debt is unchanged from the previous period.
20.65M
Equity value is unchanged from the previous period.
1.30
Equity value per share is unchanged from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$1.00
Analysts expect the stock price to increase by 29.03%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
4.55B
The estimated revenue has increased from the previous period.
-2.73B
The estimated EBITDA has decreased from the previous period.
-1.32
The estimated EPS has decreased from the previous period.
-21.03M
The estimated net income has decreased from the previous period.
-2.73B
The estimated EBIT has decreased from the previous period.
39980.93B
The estimated SG&A expenses have increased from the previous period.
